zaleplon has been researched along with Drug Withdrawal Symptoms in 8 studies
zaleplon: an azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; a hypnotic with less marked effect on psychomotor functions compared to lorazepam
zaleplon : A pyrazolo[1,5-a]pyrimidine having a nitrile group at position 3 and a 3-(N-ethylacetamido)phenyl substituent at the 7-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zaleplon is a short-acting pyrazolopyrimidine hypnotic with a rapid onset of action." | 2.69 | Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group. ( Elie, R; Emilien, G; Farr, I; Rüther, E; Salinas, E, 1999) |
| "Zaleplon is a pyrazolopyrimidine hypnotic agent which is indicated for the short term (2 to 4 weeks) management of insomnia." | 2.41 | Zaleplon: a review of its use in the treatment of insomnia. ( Dooley, M; Plosker, GL, 2000) |
| "Transient and chronic insomnia are common problems that should be clinically evaluated and appropriately treated." | 2.41 | Safety of zaleplon in the treatment of insomnia. ( Israel, AG; Kramer, JA, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marsden, J | 1 |
| White, M | 1 |
| Annand, F | 1 |
| Burkinshaw, P | 1 |
| Carville, S | 1 |
| Eastwood, B | 1 |
| Kelleher, M | 1 |
| Knight, J | 1 |
| O'Connor, R | 1 |
| Tran, A | 1 |
| Willey, P | 1 |
| Greaves, F | 1 |
| Taylor, S | 1 |
| Biggio, F | 2 |
| Gorini, G | 1 |
| Caria, S | 1 |
| Murru, L | 1 |
| Sanna, E | 1 |
| Follesa, P | 2 |
| Belleville, G | 1 |
| Morin, CM | 1 |
| Siriwardena, AN | 1 |
| Qureshi, MZ | 1 |
| Dyas, JV | 1 |
| Middleton, H | 1 |
| Orner, R | 1 |
| Elie, R | 1 |
| Rüther, E | 1 |
| Farr, I | 1 |
| Emilien, G | 1 |
| Salinas, E | 1 |
| Dooley, M | 1 |
| Plosker, GL | 1 |
| Mancuso, L | 1 |
| Cagetti, E | 1 |
| Franco, M | 1 |
| Trapani, G | 1 |
| Biggio, G | 1 |
| Israel, AG | 1 |
| Kramer, JA | 1 |
3 reviews available for zaleplon and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England.
Topics: Acetamides; Adolescent; Adult; Aged; Analgesics; Analgesics, Opioid; Antidepressive Agents; Azabicyc | 2019 |
Zaleplon: a review of its use in the treatment of insomnia.
Topics: Acetamides; Drug Interactions; Humans; Hypnotics and Sedatives; Memory; Psychomotor Performance; Pyr | 2000 |
Safety of zaleplon in the treatment of insomnia.
Topics: Acetamides; Benzodiazepines; Half-Life; Humans; Hypnotics and Sedatives; Psychomotor Disorders; Pyri | 2002 |
2 trials available for zaleplon and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Hypnotic discontinuation in chronic insomnia: impact of psychological distress, readiness to change, and self-efficacy.
Topics: Acetamides; Adaptation, Psychological; Adult; Aged; Anxiety; Attitude to Health; Azabicyclo Compound | 2008 |
Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
Topics: Acetamides; Adolescent; Adult; Aged; Ambulatory Care; Dose-Response Relationship, Drug; Double-Blind | 1999 |
3 other studies available for zaleplon and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Flumazenil selectively prevents the increase in alpha(4)-subunit gene expression and an associated change in GABA(A) receptor function induced by ethanol withdrawal.
Topics: Acetamides; Alcohol-Induced Disorders, Nervous System; Animals; Animals, Newborn; Anticonvulsants; C | 2007 |
Magic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Attitude to Health; Azabicyclo Compounds; Be | 2008 |
Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem.
Topics: Acetamides; Animals; Cells, Cultured; Diazepam; GABA Modulators; Hypnotics and Sedatives; Nuclease P | 2002 |